Drug Shortage Report for PMS-PRAVASTATIN
Report ID | 4278 |
Drug Identification Number | 02247655 |
Brand name | PMS-PRAVASTATIN |
Common or Proper name | PRAVASTATIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | PRAVASTATIN SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-23 |
Estimated end date | Unknown |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | Format discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-06-10 | French | Compare |
v5 | 2020-06-10 | English | Compare |
v4 | 2017-06-16 | French | Compare |
v3 | 2017-06-16 | English | Compare |
v2 | 2017-03-24 | French | Compare |
v1 | 2017-03-24 | English | Compare |
Showing 1 to 6 of 6